These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28100289)

  • 1. Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011-2013.
    Brouard C; Pillonel J; Sogni P; Chollet A; Lazarus JV; Pascal X; Barin F; Jauffret-Roustide M;
    Epidemiol Infect; 2017 Jan; 145(6):1-11. PubMed ID: 28100289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis.
    Rostam-Abadi Y; Rafiemanesh H; Gholami J; Shadloo B; Amin-Esmaeili M; Rahimi-Movaghar A
    Harm Reduct J; 2020 Oct; 17(1):81. PubMed ID: 33087141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.
    Mao B; Patel MK; Hennessey K; Duncan RJ; Wannemuehler K; Soeung SC
    Vaccine; 2013 Sep; 31(40):4459-64. PubMed ID: 23684825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination.
    Nguyen TH; Vu MH; Nguyen VC; Nguyen LH; Toda K; Nguyen TN; Dao S; Wannemuehler KA; Hennessey KA
    Vaccine; 2014 Jan; 32(2):217-22. PubMed ID: 24284410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.
    Sun HY; Cheng CY; Lee NY; Yang CJ; Liang SH; Tsai MS; Ko WC; Liu WC; Wu PY; Wu CH; Lin HH; Hung CC
    PLoS One; 2014; 9(2):e90194. PubMed ID: 24587275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
    Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
    Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
    BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
    Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F
    Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sibling status, home birth, tattoos and stitches are risk factors for chronic hepatitis B virus infection in Senegalese children: A cross-sectional survey.
    Périères L; Protopopescu C; Lo G; Marcellin F; Ba EH; Coste M; Touré Kane C; Diallo A; Sokhna C; Boyer S;
    J Viral Hepat; 2021 Nov; 28(11):1515-1525. PubMed ID: 34355470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization.
    Liao XY; Zhou ZZ; Wei FB; Qin HN; Ling Y; Li RC; Li YP; Nong Y; Sun KX; Li J; Zhuang H
    Hum Vaccin Immunother; 2014; 10(1):224-31. PubMed ID: 24018404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
    Garcia D; Porras A; Rico Mendoza A; Alvis N; Navas MC; De La Hoz F; De Neira M; Osorio E; Valderrama JF
    Vaccine; 2018 May; 36(19):2721-2726. PubMed ID: 29609968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018.
    Minta AA; Silva MWT; Shrestha A; de Quiroz-Castro M; Tohme RA; Quimson ME; Jiz MA; Woodring J
    Vaccine; 2021 Apr; 39(14):1982-1989. PubMed ID: 33712351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequent delayed spontaneous seroclearance of hepatitis B virus after incident HBV infection among adult high-risk groups.
    van Santen DK; Boyd A; Bruisten S; Sonder GJ; Prins M; van Houdt R
    J Viral Hepat; 2020 Jan; 27(1):81-87. PubMed ID: 31520430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey).
    Périères L; Diallo A; Marcellin F; Nishimwe ML; Ba EH; Coste M; Lo G; Halfon P; Touré Kane C; Maradan G; Carrieri P; Diouf A; Shimakawa Y; Sokhna C; Boyer S;
    Hepatol Commun; 2022 May; 6(5):1005-1015. PubMed ID: 34918868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.